Anilinoquinoline derivatives as inhibitors of subgenomic hepatitis c virus replication
- At: Istanbul (Turkey) (2009)
- Type: Poster
- By: YANG, Shyh-Chyun (Faculty of Pharmacy, Kaohsiung Medical University, Kaohsiung, China Taiwan)
- Co-author(s): Peng, Huang-Kai (Faculty of Pharmacy, Kaohsiung Medical University, KAOHSIUNG, China Taiwan)
The infection of hepatitis C virus (HCV) leads a global health problem. It affect about 170 million people suffer from chronic HCV infection which causes a progressive and critical liver disease include hepatocellular carcinoma (HCC). Herein we have developed an efficient synthetic procedure towards a series of anilinoquinoline derivatives. All.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.